Work

CRM1 Inhibition Abrogates Osteoclast Formation and Bone Resorption Via Inhibition of RANKL-Induced NFκB While Sparing Osteoblastogenesis: Further Therapeutic Implication in Multiple Myeloma

Year: 2012

Type: article

Source: Blood

DOI: 10.1182/blood.v120.21.1835.1835

Authors: Chirag Acharya, Mike Y Zhong, Yolanda Calle, Stephen Schey, Michelle Chen, Daniel Tannenbaum, Michaela R Reagan, Irene M. Ghobrial, Yosef Landesman, Sharon Shacham, Michael Kauffman, Kenneth C. Anderson, Yu-Tzu Tai

Institutions: Dana-Farber Cancer Institute, King's College London, King's College Hospital, Harvard University, Karyopharm Therapeutics (United States)

Language: English

Topic: Bone Metabolism and Diseases

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2584237372

FWCI: 0.116

Cites:

Cited by: 2

Related to: 10